세계의 욕창 치료 시장 규모는 2024년에 55억 4,000만 달러에 달했습니다. IMARC Group은 향후 2033년까지 82억 5,000만 달러에 이를 전망이며, 2025-2033년 4.30%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측하고 있습니다. 현재 북미가 시장을 독점하고 있으며 2024년 시장 점유율은 40.0%였습니다. 기술에 의한 창상 치료나 제품의 진보로 욕창 치료의 유효성은 항상 향상되고 있어 시장의 성장을 뒷받침하고 있습니다. 게다가 당뇨병, 심혈관 질환, 비만 등의 만성 질환의 증가도 시장에 긍정적인 영향을 주고 있습니다. 이와는 별도로, 재택 간병 서비스의 수요 증가가 욕창 치료 시장의 점유율을 확대하고 있습니다.
조기 개입과 적절한 관리의 중요성에 대한 의식이 높아짐에 따라, 욕창 치료 시장은 확대되고 있습니다. 의료 종사자들은 특히 노인이나 만성 질환을 가진 사람들 사이에서 증가하는 욕창 유병률에 대처하기 위해 항상 새로운 솔루션을 모색하고 있습니다. 또, 의료 기술의 혁신으로 하이테크 창상 케어 제품 및 치료법이 탄생해, 시장도 확대되고 있습니다. 이러한 진보는 환자의 전귀를 향상시켜, 헬스 케어 시스템의 비용 부담을 경감시키고 있습니다. 심혈관 질환 및 당뇨병 등 만성질환의 증가가 욕창 치료의 필요성을 높이고 있습니다.
미국의 욕창 치료 시장은 헬슼케어 제공 및 치료 전략에 영향을 미치는 다양한 요인의 존재에 의해 강력하게 성장하고 있습니다. 헬스케어 종사자들은 욕창 관리 방법의 강화에 힘쓰고 있으며, 조기 발견과 새로운 치료법의 선택에 중점을 두고 있습니다. 치료되지 않은 욕창이 중대한 영향을 끼친다는 인식이 높아지면서 환자와 헬스케어 종사자 모두 효과적이고 시의적절한 치료를 요구하고 있습니다. 이러한 인식의 고조는 첨단 드레싱재, 항균 치료, 욕창 완화 기구 등 보다 광범위한 창상 케어 제품에 대한 수요를 촉진하고 있습니다. IMARC Group은, 창상 케어 시장이 2025-2033년 4.28%의 성장률(CAGR)을 나타낼 것으로 예측하고 있습니다.
만성 질환 증가 및 노화
당뇨병, 심혈관 질환, 비만 등의 만성 질환의 유병률의 상승이, 욕창 치료 수요를 견인하고 있습니다. 이 질환은 항상 혈액 순환의 악화나 운동 능력의 저하로 이어지므로, 환자는 욕창을 발병하기 쉬워집니다. 또한 노인 인구도 큰 요인입니다. 노인은 허약체질이며, 너싱홈이나 병원과 같은 의료환경에서는 장시간 움직일 수 없기 때문에 더욱 취약합니다. 2024년 세계 평균 수명은 73.3세로 1995년부터 8.4년 늘었습니다. 유엔의 데이터에 따르면 2024년에는 전 세계 65세 이상 고령자가 약 8억 3,000만 명이 되었습니다. 이를 위해 헬스케어 시스템은 욕창 위험을 최소화하기 위해 환자의 정기적인 뒤척임, 복잡한 창상피복, 압박완화장치 등의 예방적 개입을 지속적으로 강조하고 있습니다. 또한 헬스케어 전문가들은 치유율을 높이고 합병증을 최소화하기 위해 조기 발견과 완전한 치료 프로토콜을 강조하고 있습니다. 이러한 만성질환 관리 및 노인 돌봄에 대한 관심의 증대는 욕창 치료 시장을 지속적으로 확대하고 있습니다.
재택 간병 및 외래 환자 서비스에 대한 수요 증가
재택 간병 서비스에 대한 수요 증가는 욕창 치료 시장 전망을 양호하게 하고 있습니다. 간병인도 환자도 보다 편리하고 저렴한 치료를 항상 요구하고 있으며, 그 결과 욕창의 치료가 병원이나 간병시설이 아닌 자택에서 이루어지는 경우가 증가하고 있습니다. 고급 드레싱재, 욕창 완화기기, 원격 모니터링 시스템 등의 재택 케어 제품이 인기를 끌고 있습니다. 헬스케어 전문가들은 환자 교육이나 맞춤형 케어 플랜을 통해 환자가 가정 환경에서 욕창을 관리할 수 있도록 치료 절차를 재검토하는 경우가 많아지고 있습니다. 이 동향이 재택 케어를 베이스로 한 창상 관리 제품이나 서비스의 수요를 견인하고 있습니다. 게다가 원격의료나 디지털 헬스 기술의 이용이 진행됨에 따라 헬스케어 종사자가 원격으로 치료를 모니터링하거나 미세 조정할 수 있게 되어 재택에서의 욕창 치료를 더욱 뒷받침하고 있습니다. 이러한 외래 및 재택 케어 서비스로의 지속적인 전환은 시장을 더욱 큰 폭으로 확대시키고 있습니다. IMARC Group은 원격 의료 시장이 2033년까지 5,399억 5,000만 달러에 이를 것으로 예측하고 있습니다.
창상 케어의 기술적 진보
기술에 의한 창상 케어 치료와 제품의 진보는 욕창 치료의 효과를 지속적으로 향상시키고 욕창 치료 시장의 성장을 가속하고 있습니다. 하이드로콜로이드, 폼, 알긴산 드레싱재 등 세련된 창상 피복재 개발로 치유 속도 및 감염 예방이 향상되고 있습니다. 치료자는 보다 효율적이고 외상이 적은 치료법을 제공하기 위해 이러한 진보를 점점 도입하게 되고 있습니다. 음압창상치료(NPWT)는 조직의 성장을 촉진하고 부종을 최소화함으로써 치유를 촉진하기 위해 큰 기세를 보이고 있습니다. 항균요법, 성장인자, 생물학적 요법의 개발이 진행되고 있으며, 기존의 치료법을 대체할 수 있는 개선책을 환자에게 제공함으로써 시장 개척에 박차를 가하고 있습니다. 또, 이러한 기술은, 환자를 병원으로부터 멀리 해, 합병증을 회피하는 것으로, 헬스케어 전체의 비용을 삭감하는데도 공헌하고 있기 때문에, 헬스케어 환경 전체에 대한 보급이 진행되어 욕창 치료 시장의 성장을 한층 더 촉진하고 있습니다. 2025년, 그루포 산 도나트는 만성 창상 치료를 강화하기 위한 독자적인 창상 치료 네트워크를 발표했습니다. 이 네트워크는 몬자의 Istituti Clinici Zucchi와 IRCCS Ospedale San Raffale의 2개의 HUB 병원을 중심으로 조직되며, 가장 복잡한 사례에 고도의 지원을 제공합니다. 그룹 내 나머지 병원은 스포크 센터로 운영되어 지역 전체에서 광범위하고 신속한 치료를 제공합니다.
The global pressure ulcers treatment market size was valued at USD 5.54 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 8.25 Billion by 2033, exhibiting a CAGR of 4.30% from 2025-2033. North America currently dominates the market, holding a market share of 40.0% in 2024. Advances in wound care treatments and products through technology are constantly improving pressure ulcer treatment effectiveness, thereby impelling the market growth. Moreover, the growing incidence of chronic conditions like diabetes, cardiovascular diseases, and obesity is positively influencing the market. Apart from this, the rise in the demand for homecare services is expanding the pressure ulcer treatment market share.
The market for pressure ulcers treatment is growing due to the heightened awareness about the significance of early intervention and proper management. Medical professionals are always seeking newer solutions to deal with the increasing prevalence of pressure ulcers, especially among the elderly and those with chronic diseases. The market is also growing due to innovations in medical technology, which are resulting in the creation of high-tech wound care products and treatments. These advances are enhancing patient outcomes and lowering the cost burden on healthcare systems. The incidence of chronic illnesses, including cardiovascular diseases and diabetes, is catalyzing the need for pressure ulcer treatments.
The United States market for pressure ulcer treatment is growing strongly with the presence of a range of factors influencing healthcare provision and treatment strategies. Healthcare practitioners are making efforts to enhance their methods of pressure ulcer management, emphasizing early identification and new treatment choices. Increasing recognition regarding the grave implications of untreated pressure ulcers is prompting patients and healthcare practitioners alike to seek effective and timely treatment. This increased recognition is driving the demand for more extensive wound care products, such as advanced dressings, antimicrobial treatments, and pressure relief devices. The IMARC Group predicts that the wound care market is expected to demonstrate a growth rate (CAGR) of 4.28% during 2025-2033.
Growing Incidence of Chronic Illnesses and Aging Population
The rising prevalence of chronic conditions like diabetes, cardiovascular diseases, and obesity is driving the need for pressure ulcers treatment demand. Since these illnesses always lead to poor blood circulation and reduced mobility, patients are more likely to acquire pressure ulcers. The older population is also a major factor, as older people are more vulnerable due to frailty and extended periods of immobility, typically in medical environments such as nursing homes or hospitals. Worldwide, life expectancy at birth hit 73.3 years in 2024, marking a rise of 8.4 years since 1995. There were around 830 million people aged 65 and older around the world in 2024, as per the UN data. Owing to this, healthcare systems are continually emphasizing preventative interventions, such as routine turning of patients, complex wound dressings, and pressure relief devices, to minimize the risks of pressure ulcers. In addition, healthcare professionals are stressing early identification and full treatment protocols to improve healing rates and minimize complications. This increasing stress on chronic disease management and care for the elderly is continuously expanding the pressure ulcers treatment market.
Escalating Demand for Homecare and Outpatient Services
The rise in the demand for homecare services is offering a favorable pressure ulcers treatment market outlook. Caregivers and patients alike are constantly looking for treatments that are more convenient and less expensive, resulting in pressure ulcers being increasingly treated at home instead of in a hospital or nursing home. Homecare products, such as advanced dressings, pressure-relieving equipment, and remote monitoring systems, are gaining traction. Healthcare professionals are revising treatment procedures to ensure patients can manage pressure ulcers in home environments, often through patient education and tailored care plans. This trend is driving the demand for homecare-based wound management products and services. Additionally, the heightened usage of telemedicine and digital health technologies is allowing healthcare practitioners to remotely monitor and fine-tune treatments, further supporting home-based treatment of pressure ulcers. This ongoing shift towards outpatient and homecare services is further broadening the market substantially. The IMARC Group predicts that the telemedicine market is projected to attain USD 539.95 Billion by 2033.
Technological Advancements in Wound Care
Advances in wound care treatments and products through technology are constantly improving pressure ulcer treatment effectiveness, thereby impelling the pressure ulcer treatment market growth. The creation of sophisticated wound dressings, including hydrocolloid, foam, and alginate dressings, is enhancing the rate of healing and infection prevention. Providers are increasingly implementing these advances to offer more efficient and less traumatic treatment methods. In addition, negative pressure wound therapy (NPWT) is picking up massive momentum since it stimulates healing by encouraging tissue growth and minimizing edema. The ongoing development of antimicrobial therapies, growth factors, and biological therapies is fueling the market growth by providing patients with improved alternatives to conventional therapies. These technologies are also assisting in decreasing the overall costs of healthcare by keeping patients short of hospitals and avoiding complications, thus increasing their uptake across healthcare settings, further driving the pressure ulcer treatment market growth. In 2025, Gruppo San Donato unveiled a unique wound care network for enhancing chronic wound treatment. The network will be organized around two HUB hospitals, Istituti Clinici Zucchi in Monza and IRCCS Ospedale San Raffaele, offering advanced assistance for the most complicated cases. The remaining hospitals in the Group will operate as Spoke Centers, providing extensive and prompt care throughout the area.
Stage 4 stand as the largest component in 2024, holding 39.8% of the market. The increasing prevalence of Stage 4 pressure ulcers is becoming problematic within the healthcare environment, especially among immobile or chronically ill patients. Stage 4 pressure ulcers are the worst kind, involving full-thickness tissue loss, usually with exposed muscle, bone, or tendons. The advancement is also often the result of delayed treatment or suboptimal care since pressure ulcers can be exacerbated if not addressed early. The growing population of patients with diabetes, obesity, and neurological disorders is driving this trend because these disorders tend to compromise circulation, mobility, and general healing of wounds, thus predisposing patients to deeper ulcers. With the aging population growing, there is also an increased risk for Stage 4 pressure ulcers because elderly patients are especially susceptible to immobility for long periods and skin weakness. The incidence of immobility coupled with decreased sensation and poor diet directly contributes to the formation of such severe ulcers.
Wound-care dressings lead the market with 65.4% of market share in 2024. Wound-care dressings are formatted to develop a healing environment that is optimal through sustaining moisture balance around the wound area. This promotes accelerated healing, minimizes dehydration of tissues, and aids in cell regeneration. More advanced types of dressings, including hydrocolloids, foams, and alginates, are continually being formulated to trigger faster healing by giving the amount of moisture and temperature regulation that strengthens tissue repair. These dressings are especially useful in the context of chronic wounds, in which healing is otherwise slow and complex. One of the key roles of wound-care dressings is to serve as a barrier to external infectants, such as bacteria, dirt, and other pathogens. Dressings decrease infection risk by covering the wound and excluding direct contact with the environment, thus being a key point of concern in wound care. Most contemporary dressings include antimicrobial activity, like silver or iodine, which actually prevents dangerous microorganisms from multiplying and improves a more hygienic healing process. This prevention of infection is especially important for those who have chronic illnesses, like diabetes, who are at greater risk for wound infections.
Hospitals lead the market with 62.3% of market share in 2024. Hospitals are a significant end-user in the market, playing a crucial role in the management and care of patients suffering from severe wounds, including pressure ulcers. Within the hospital setting, patients who are bedridden, immobile, or suffering from chronic conditions such as diabetes, neurological disorders, or cardiovascular diseases are at an elevated risk of developing pressure ulcers. These patients often require advanced wound care, which includes the use of specialized dressings, pressure-relieving devices, and wound therapies. Hospitals are continuously adopting the latest medical technologies and treatment options to improve patient outcomes. The availability of skilled healthcare professionals and advanced medical equipment in hospitals allows for the early detection and aggressive management of pressure ulcers. Healthcare providers are also focusing on preventative measures, such as regular repositioning, the use of pressure-relieving mattresses, and monitoring devices, to reduce the occurrence of these ulcers among hospitalized patients.
In 2024, North America accounted for the largest market share of over 40.0%. The North America pressure ulcers treatment sector is experiencing steady growth, driven by rising healthcare awareness, an aging population, and the increasing prevalence of chronic conditions. Healthcare providers across the region are continuously focusing on early intervention and advanced treatment strategies to reduce the incidence and severity of pressure ulcers. Long-term care facilities, hospitals, and home healthcare providers are adopting innovative wound care solutions, which is catalyzing the demand for pressure ulcers treatment products and services. Chronic diseases such as diabetes, obesity, and vascular disorders are becoming more common in North America, leading to a higher risk of pressure ulcer development, especially among immobile and elderly patients. Healthcare systems are responding by investing in better patient management protocols, including regular risk assessments, patient repositioning techniques, and the use of pressure-relieving devices. These practices are forming the backbone of preventative strategies, which are being widely implemented to address the increasing pressure ulcer burden.
United States Pressure Ulcers Treatment Market Analysis
The United States holds 85.50% share in North America. The United States is witnessing increased pressure ulcers treatment adoption due to the growing obesity rates, which have significantly heightened the risk of immobility-related skin conditions. For instance, approximately 3 in 4 adults in the U.S. are regarded as overweight or have obesity, according to a 2024 study. As obesity often leads to limited physical movement, individuals are more prone to developing pressure ulcers, particularly in long-term care settings. Healthcare providers are focusing more on pressure ulcers treatment to reduce complications associated with obesity-induced skin breakdowns. Enhanced awareness among healthcare professionals, alongside better reimbursement policies, is also encouraging the implementation of pressure ulcers treatment solutions. Technological advancements in wound care and patient support systems are complementing the need for effective treatment modalities. The rise in bariatric patients is further pushing hospitals to improve treatment protocols, positioning pressure ulcers treatment as a critical component in managing obesity-related complications in the United States.
Asia Pacific Pressure Ulcers Treatment Market Analysis
Asia-Pacific is experiencing accelerated pressure ulcers treatment adoption driven by a growing number of ulcers cases across diverse patient demographics. For instance, in India, the occurrence of pressure ulcers in hospitalized patients has been reported to be 4.94% in a study conducted. The rising incidence is linked to aging populations, increased hospitalization, and prolonged bed rest among patients suffering from critical illnesses. These conditions elevate susceptibility to ulcers, prompting a surge in demand for preventive and therapeutic options. Healthcare systems are emphasizing training programs, early intervention techniques, and access to cost-effective treatment protocols. The region is also witnessing technological advancements in wound care, improving treatment efficacy and patient outcomes. Investments in medical infrastructure and policy support are enabling broader accessibility to ulcer care.
Europe Pressure Ulcers Treatment Market Analysis
Europe is seeing rising pressure ulcers treatment adoption due to growing chronic medical diseases that lead to extended periods of immobility among patients. A study of OECD nations, in February 2025, across the EU, has revealed that approximately eight in ten individuals aged 45 and above who consulted a primary care worker during the last six months have a minimum of one long-term condition. Conditions such as diabetes, vascular disorders, and neurological impairments significantly increase the risk of pressure ulcer development. As chronic diseases become more prevalent, hospitals and care facilities are implementing comprehensive ulcer management programs to mitigate complications. The region is actively integrating evidence-based therapies, including advanced dressings and negative pressure wound therapy, to support recovery. Collaborative healthcare policies and reimbursement frameworks are supporting access to effective treatments. Medical professionals are emphasizing routine screening and timely interventions to manage chronic disease-related ulcers.
Latin America Pressure Ulcers Treatment Market Analysis
Latin America is undergoing a steady expansion in hospitals and clinics, supporting pressure ulcers treatment adoption across healthcare facilities. For instance, in Brazil, the incidence of PUs has been estimated to range from 10.8% to 25.6%, being more common in ICU patients and less common among older individuals residing in long-term care facilities. Increased access to care and healthcare investments are encouraging early diagnosis and effective treatment of pressure ulcers. New hospitals are being equipped with specialized wound care units to manage pressure ulcers efficiently. Clinics are also integrating standard treatment protocols to reduce ulcer-related complications and hospital readmissions.
Middle East and Africa Pressure Ulcers Treatment Market Analysis
The Middle East and Africa are recording higher pressure ulcers treatment adoption due to the growing prevalence of ulcer diseases linked to aging populations and chronic health conditions. For instance, in Saudi Arabia, the proportion of the older population (60+) varied between 5.59% and 6.9% of the population from 2020 to 2022. The increasing burden of pressure ulcers is compelling healthcare providers to adopt improved wound care practices. Rising awareness and availability of treatment products are enhancing disease management capabilities. As ulcer diseases continue to escalate, hospitals and clinics are prioritizing preventive care and advanced therapies to manage pressure ulcers more effectively in the region.
Market players in the pressure ulcers treatment sector are actively engaging in product improvement, strategic collaborations, and geographical expansion to strengthen their market position. Leading companies are continuously developing advanced wound care solutions, including specialized dressings, negative pressure wound therapy devices, and antimicrobial treatments. They are also focusing on enhancing the effectiveness of existing products through research and development. Additionally, players are forming partnerships with healthcare providers and research institutions to improve clinical outcomes and expand product offerings. Many companies are also entering emerging markets, where the demand for advanced pressure ulcer treatments is growing, further diversifying their product portfolios and increasing global reach. As per the pressure ulcers treatment market forecast, these activities are expected to drive competition and accelerate market growth.